Bio-Pharma

• 

  Milestone Pharmaceuticals randomises first patient in Phase 3 clinical trial

  August 9, 2018 • Bio-Pharma, Clinical Trials, Feature Slider, Feature-Home, Featured-Slides-Home • 318

  Milestone Pharmaceuticals, a clinical-stage cardiovascular company, has randomised the first patient in its Phase 3 clinical...

• 

  Zymeworks and Celgene to expand bispecific antibody collaboration

  April 24, 2018 • Bio-Pharma, Feature Slider, Feature-Home, Featured-Slides-Home, Uncategorized • 324

  Vancouver-based Zymeworks Inc., a biopharmaceutical company, and the biotech giant Celgene Corporation announce that they have...

• 

  Biolab – beating at the heart of it

  November 29, 2017 • Bio-Pharma, Business Focus, Feature, Feature Slider, Feature-Home, Featured-Slides-Home • 511

  There are many reasons that Mississauga has become an exceptional place to set up shop in the life sciences community. So many in...

• 

  Policy changes in dealing with MS sought

  April 27, 2017 • Bio-Pharma, Drug Development, Feature Slider, Featured-Slides-Home, Policy/Regulatory/IP, Science Focus • 397

  An estimated 100,000 people living in Canada are suffering from multiple sclerosis –  that is the highest ratio of MS...

• 

  InSymbiosis partners with Jupiter Orphan

  April 26, 2017 • Bio-Pharma, Business Focus, Clinical Trials, Feature Slider, Featured-Slides-Home, Management Updates • 272

  Montreal-based biotechnology company InSymbiosis is collaborating with Jupiter Orphan Therapeutics Inc.(JOT) in managing the...

• 

  Report says pharmocogenomics has not fulfilled its promise to developing countries

  April 14, 2014 • Bio-Pharma, Feature, Pharmacogenomics, Science Focus • 3477

  From 1997 to 2010, despite promises made by the international scientific community, pharmacogenomic research produced few studies...

• Dalton Medicinal Chemistry given notice of funding renewal from NIDA of NIH

  April 14, 2014 • Bio-Pharma, Business Focus, Management Updates • 1889

  Dalton Medicinal Chemistry has received notice that the award from the National Institute On Drug Abuse (NIDA) to research and...

• Cardiome to distribute BRINAVESS in Spain

  March 28, 2014 • Bio-Pharma, Business Focus, Deals/M&A/Collaboration • 2021

  Cardiome Pharma Corp. has entered into a distribution agreement with Logista Pharma S.A., headquartered in Madrid, Spain, to...

• Aquinox Pharmaceuticals prices initial public offering

  March 11, 2014 • Bio-Pharma, Business Focus, Capital markets/Funding • 2005

  Aquinox Pharmaceuticals, Inc. has announced the pricing of its initial public offering of 4,200,000 shares. The common stock will...

• 

  BC researcher closing in on Chlamydia vaccine

  March 3, 2014 • Bio-Pharma, Drug Development, Science Focus • 2083

  Genome BC’s Proof-of-Concept funding program is helping to develop a new vaccine for one of the most widespread sexually...